|1.||Waters, Susanna: 2 articles (11/2014 - 01/2014)|
|2.||Waters, Nicholas: 2 articles (11/2014 - 01/2014)|
|3.||Klamer, Daniel: 2 articles (11/2014 - 01/2014)|
|4.||Ponten, Henrik: 2 articles (11/2014 - 01/2014)|
|5.||Iuvone, P Michael: 2 articles (12/2013 - 01/2013)|
|6.||Goldstein, David S: 2 articles (01/2013 - 08/2009)|
|7.||Pletnikov, Mikhail V: 2 articles (06/2012 - 11/2007)|
|8.||Lin, Bao-Cheng: 2 articles (06/2010 - 07/2009)|
|9.||Liu, Wen-Yan: 2 articles (06/2010 - 07/2009)|
|10.||Szyndler, Janusz: 2 articles (06/2010 - 07/2002)|
|1.||Parkinson Disease (Parkinson's Disease)
01/01/2002 - "COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease."
08/01/1995 - "These results point towards a diffuse neuronal dysfunction in Parkinson's disease and indicate that lumbar csf NE and csf DOPAC are of central nervous origin."
12/01/1986 - "Based on the levels of ACE activity, DOPAC, and HVA per milliliter of CSF, two discriminant functions were derived and resulted in the correct classification of 71% of all subjects (n = 38) into Alzheimer's disease, Parkinson's disease, and neurologically healthy control groups."
08/01/2003 - "Significantly lower concentrations of the dopamine metabolite 3,4-dihydroxyphenylacetic acid in the Parkinson's disease group might reflect dopaminergic cell loss. "
01/01/2003 - "Daily urinary catecholamine excretion (DOPA, DA, DOPAC, NA, A) was studied in 66 patients with Parkinson's disease, 38 of them with differently expressed depression. "
01/01/1997 - "A single dose of LTG (20 mg/kg) prevented audiogenic seizures in seizure-prone mice, while reducing substantially the striatal content of the DA metabolite, DOPAC (to less than 50% of saline-injected controls) in both seizure-resistant and seizure-prone mice. "
08/01/1994 - "Stimulation of the kindled hippocampus that produced stage 3 seizures evoked a brief increase in extracellular DA and DOPAC levels in the contralateral nucleus accumbens. "
01/01/1997 - "Lamotrigine (LTG), an anticonvulsive drug, was tested for its effects on striatal content of DA and its metabolites, DOPAC and HVA, in audiogenic seizure-resistant (ER) and audiogenic seizure-prone (EP) lines of Balb/c mice. "
10/22/1986 - "During tonic convulsions, the amplitude of the DOPAC oxidation peak significantly decreased to 75% of the peak height recorded prior to the injection of PTZ, and the minimum lasted for about 30 min; then the mean curve slowly recovered to the control level within 60 min. These results suggest that the release of dopamine (DA) in the caudate nucleus of freely moving rats decreased during tonic convulsions induced by PTZ. "
12/01/1983 - "Neurochemically, there was a marked decrease in noradrenaline levels (up to 70%) and an increase in levels of 5-hydroxyindoleacetic acid, 3,4-dihydroxyphenylacetic acid and homovanillic acid (up to 200%) in all analysed brain regions, suggesting a strongly increased firing rate of aminergic neurones during the period of generalized seizures. "
06/01/1991 - "We found that borderline hypertensive patients compared with controls 1) showed a higher baseline urinary excretion of methoxytyramine, a marker of exocytotic dopamine release, with a greater DOPA-induced decrease of systolic blood pressure without reflex tachycardia; 2) had in response to DOPA a blunted plasma DOPA and free dopamine increase but an accentuated plasma dopamine sulfate and urinary DOPAC excretion; and 3) eliminated comparable quantities of dopamine in urine despite a lower rise in the glomerular DOPA load. "
|4.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/01/2000 - "Neurochemical analysis from these animals revealed that the alcohol-dependent animals displayed a significant reduction of DOPAC and 5-HIAA levels in the striatum, frontal cortex, and hypothalamus after a 9-h withdrawal period, further implicating the serotonergic and dopaminergic systems in mediation of withdrawal symptoms and alcohol craving. "
01/01/1998 - "The DA and DOPAC levels were decreased by preadministration of SRBT (600 mg/kg, p.o.) in the last two models, but were not altered in electric shock stress. "
05/01/1991 - "However, 30 min of intermittent tail shock produced a greater elevation of extracellular NE and 3,4-dihydroxyphenylacetic acid in the chronically cold-stressed rats than in the native controls. "
01/01/1991 - "In the mesocortex and nucleus accumbens shock induced an increase of DOPAC accumulation and pronounced reductions of DA in some strains, while in others these variations were less pronounced or entirely absent. "
02/24/1987 - "A marked rise in DOPAC content (+80%) and a significant decrease in DA levels (-23%) were observed after a 20 min foot-shock session. "
02/24/1987 - "The effects of electric foot-shock on the activity of the mesocortical dopaminergic (DAergic) neurons were estimated by measuring the changes in dihydrophenylacetic acid (DOPAC) and DA content in the prefrontal cortex of the rat. "
|5.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
|8.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|9.||Ephrin-A5 (Ephrin A5)
|2.||Transplantation (Transplant Recipients)